Why Roche is the World's Most Sustainable Healthcare Company

Roche earned recognition as the second most sustainable company in the world for 2025, according to Sustainability Magazine's Top 250 World's Most Sustainable Companies list.

This placement reflects the company's deep integration of sustainability within its global operations, from AI-led cancer diagnostics to long-term environmental and social commitments.

As the world’s largest biotech firm, Roche continues to influence global healthcare and diagnostics not only through innovation but also through its strategic approach to sustainability.

The ranking confirms its status as a key player driving ethical, environmental and socially responsible business practices in the life sciences sector.

Recognition for sustainability leadership in healthcare

The annual list, compiled by Sustainability Magazine, evaluates corporate sustainability based on environmental, social, governance and strategic innovation metrics.

Each of the 250 companies is assessed on a 400-point scale, measuring their performance across four key dimensions:

• Environmental impact

• Social responsibility

• Governance and transparency

• Strategy and innovation

Roche secured its place near the top by scoring consistently across all categories.

Its strong environmental targets, ethical operations and forward-thinking approach to healthcare innovation position it as a model for sustainable enterprise.

“It gives me immense pride to publish the expanded list of the Top 250 World's Most Sustainable Companies, especially as I’ve got to know so many of the amazing companies on the list,” says Glen White, CEO of BizClik and Sustainability Magazine.

“I recognised at our inaugural Climate Week NYC event last September, that we have started to build something quite special with Sustainability Magazine and Sustainability LIVE – a collective collaboration of like-minded individuals and teams all committed to achieving long-term programmes to protect our planet.”

Roche’s approach to corporate sustainability

Based in Basel, Switzerland, Roche remains a leader in biotechnology, pharmaceuticals and diagnostics.

Its operations span more than 100 countries, with a workforce of over 100,000 people.

The company focuses on personalised healthcare in areas such as oncology, immunology, infectious diseases and ophthalmology.

While its medical portfolio continues to evolve, Roche weaves sustainability into its business model at every level. Environmental stewardship, responsible sourcing and social impact form part of the company’s core strategic framework.

Roche sets clear targets, including a commitment to reach net zero carbon emissions by 2045.

It also embeds business ethics, transparency and active stakeholder engagement into its global operations.

Chief Executive Thomas Schinecker oversees these priorities as part of the company’s broader mission to save lives through innovation while protecting the planet and strengthening society.

Innovation meets sustainability in diagnostics and AI

Roche invests heavily in research and development to advance personalised medicine, especially in cancer diagnostics.

Its work in AI-powered diagnostics enhances early detection and treatment pathways for critical conditions, reflecting the company’s blend of medical progress and long-term impact.

This scientific investment also reinforces Roche’s position within the sustainability rankings.

Strategy and innovation form one of the four pillars in the Top 250 evaluation, and Roche continues to meet this with ongoing breakthroughs and technology integration.